FIBROGEN INC — Director's Dealing 2022

Dec 15, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2022-12-08

Reporting Person: Graham Juan (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-08	Common Stock	S	5263	$14.84	Disposed	50628	Direct
2022-12-08	Common Stock	S	478	$15.47	Disposed	50150	Direct

Footnotes

F1: Shares sold pursuant to a 10b5-1 plan.

F2: These shares were sold in multiple transactions on the reported date with prices ranging from $14.38 to $15.355 resulting in a weighted average price of $14.84. Upon request, the reporting person will provide to the Commission staff or a security holder of the Issuer the number of shares sold and the sale price for each separate transaction.